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RaOBJECTIVES The goal of this study was to compare the risk of stroke between patients with carotid artery disease with
and without the presence of intraplaque hemorrhage (IPH) on magnetic resonance imaging.
BACKGROUND IPH in carotid stenosis increases the risk of cerebrovascular events. Uncertainty remains whether risk of
stroke alone is increased and whether stroke is predicted independently of known risk factors.
METHODS Data were pooled from 7 cohort studies including 560 patients with symptomatic carotid stenosis and
136 patients with asymptomatic carotid stenosis. Hazards of ipsilateral ischemic stroke (primary outcome) were compared
between patients with and without IPH, adjusted for clinical risk factors.
RESULTS IPH was present in 51.6% of patients with symptomatic carotid stenosis and 29.4% of patients with
asymptomatic carotid stenosis. During 1,121 observed person-years, 66 ipsilateral strokes occurred. Presence of IPH at
baseline increased the risk of ipsilateral stroke both in symptomatic (hazard ratio [HR]: 10.2; 95% conﬁdence interval
[CI]: 4.6 to 22.5) and asymptomatic (HR: 7.9; 95% CI: 1.3 to 47.6) patients. Among patients with symptomatic carotid
stenosis, annualized event rates of ipsilateral stroke in those with IPH versus those without IPH were 9.0% versus 0.7%
(<50% stenosis), 18.1% versus 2.1% (50% to 69% stenosis), and 29.3% versus 1.5% (70% to 99% stenosis). Annualized
event rates among patients with asymptomatic carotid stenosis were 5.4% in those with IPH versus 0.8% in those
without IPH. Multivariate analysis identiﬁed IPH (HR: 11.0; 95% CI: 4.8 to 25.1) and severe degree of stenosis (HR: 3.3;
95% CI: 1.4 to 7.8) as independent predictors of ipsilateral stroke.
CONCLUSIONS IPH is common in patients with symptomatic and asymptomatic carotid stenosis and is a stronger
predictor of stroke than any known clinical risk factors. Magnetic resonance imaging might help identify patients with
carotid disease who would beneﬁt from revascularization. (J Am Coll Cardiol Img 2019;-:-–-) © 2019 The Authors.
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ABBR EV I A T I ON S
AND ACRONYMS
AER = annualized event rate
AFx = amaurosis fugax
CI = conﬁdence interval
HR = hazard ratio
IPH = intraplaque hemorrhage
MRI = magnetic resonance
imaging
TIA = transient ischemic attack
Okayama,
Vascular Su
Biomedical
Stroke Cen
Saam are jo
Esposito-Ba
study. Dr. Y
from Taked
grants from
Society for
Siemens H
outside the
Dr. Auer ha
Research fo
Foundation
Foundation
Medical, ou
this paper
Manuscript
Schindler et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9
Carotid Plaque Hemorrhage Predicts Stroke - 2 0 1 9 :- –-
2A therosclerotic stenosis of the inter-nal carotid artery is present in 1%to 2% of the adult population and is
the cause ofw10% to 15% of ischemic strokes
(1,2). Randomized trials showed that carotid
endarterectomy reduces the risk of stroke in
patients with recently symptomatic carotid
stenosis (3,4) and, to a lesser degree, in pa-
tients with asymptomatic carotid stenosis
(5,6). Carotid artery stenting is an option to
surgery in selected patients with symptom-atic (7) and asymptomatic (8,9) carotid stenosis. How-
ever, the risk of stroke in patients with carotid disease
has decreased owing to more efﬁcient medical man-
agement, and, in many patients, carotid revasculari-
zation may no longer offer additional beneﬁt.
Identifying patients at high risk for stroke is therefore
essential for targeting invasive treatments to individ-
ual patients.
Magnetic resonance imaging (MRI) is able to detect
features of unstable carotid plaques such as intra-
plaque hemorrhage (IPH), lipid-rich necrotic core,
and thin or ruptured ﬁbrous cap with good histo-
pathological correlation (10–13). Several cohort
studies and 4 meta-analyses have reported a 4- to 12-
fold increased risk for ipsilateral ischemic events
(including stroke, transient ischemic attack [TIA], and
amaurosis fugax [AFx]) in patients with IPH under
medical therapy (14–17). However, the studies were
limited by small sample sizes (25 to 179 individuals)
and variations in MRI protocols to detect and classify
IPH. Reliable quantiﬁcation of stroke risk, especially
for symptomatic patients with low-grade stenosis, is
lacking. Finally, it remained unclear if detection of
IPH adds prognostic value to existing, validated
clinical risk models. To overcome these limitations,Japan; kDepartment of Neurosurgery, Graduate School of Medici
rgery, Sunnybrook Health Sciences Centre, University of Toro
Research Centre, University of Nottingham, Nottingham, United
ter, Department of Clinical Research, University Hospital Basel, Un
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received October 15, 2018; revised manuscript received March 2we pooled data of individual patients who were
examined by using plaque MRI for the presence of
IPH and prospectively followed up in several cohort
studies that used similar designs, methods, and
outcomes.
METHODS
SEARCH STRATEGY AND STUDY SELECTION
CRITERIA. Two experienced authors (A.S. and T.S.)
identiﬁed potentially eligible studies by electronic
literature searches on Ovid MEDLINE, EMBASE, and
Cochrane from inception until December 2016
(Supplemental Appendix, Supplemental Tables 1 to
5). Further eligible studies were identiﬁed by
screening of bibliographies of retrieved original pa-
pers, review articles, and published meta-analyses.
Finally, we contacted experts in the ﬁeld to identify
any additional relevant studies. Disagreements on
study inclusion were solved by discussion between
the 2 reviewers.
The pre-deﬁned eligibility criteria for studies were:
1) inclusion of $10 patients; 2) assessment of carotid
IPH on MRI at baseline (as deﬁned later) at $1.5-T; 3)
evaluation of the degree of carotid stenosis; and 4)
prospective clinical follow-up under conservative
therapy (patients in whom revascularization was
initially planned were excluded). IPH had to be
determined on T1-weighted fat-suppressed images by
the investigators of the original studies and was
deﬁned as an area of hyperintense signal in the pla-
que compared with the sternocleidomastoid muscle
or the normal vessel wall.
We invited all corresponding, ﬁrst, and last authors
of publications from eligible cohorts to share anony-
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FIGURE 1 Study Flowchart
2363 studies identified through multiple
          database searching
1907 titles and abstracts screened
1837 studies excluded based on title and abstract review
456 duplicates removed
70 full text articles assessed for eligibility
57 Full-text articles excluded *
• 34 No follow-up provided / retrospective study design
• 9 overlapping study population
• 1 Number of IPH not provided
• 1 IPH not diagnosed by fat-saturated T1w sequences
• 4 Immediate carotid endarterectomy or stenting
  (i.e. without clinical follow-up prior to therapy)
• 8 No cerebrovascular endpoints provided
13 Studies eligible for inclusion; study
     investigators invited to share individual
     subject data
7 Studies included in qualitative synthesis
   and meta-analysis (696 subjects) *
6 Studies excluded because investigators did not
   provide individual subject data (563 subjects) *
• 4 studies from 2 centers; concerns with data
  protection
• 2 no response to invitation
Study selection ﬂow diagram adapted from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses group statement (41).
*Supplemental Appendix. IPH ¼ intraplaque hemorrhage.
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3raw data were collected. The local ethics committee
waived the need for individual consent or speciﬁc
approval for this analysis.
DATA COLLECTED. Data on the following baseline
patient characteristics were collected: symptomatic
versus asymptomatic stenosis, presence or absence of
IPH, degree of stenosis, age, sex, diabetes, smoking
status, hypertension, and statin medication. Symp-
tomatic carotid stenosis was deﬁned by occurrence of
ipsilateral ischemic symptoms in the past 6 months
(retinal ischemia including retinal infarction and AFx,
TIA, or ischemic stroke).
Carotid stenosis was assessed by duplex ultra-
sound (n ¼ 6), computed tomography angiography(n ¼ 2), or magnetic resonance angiography (n ¼ 2).
Degree of stenosis was expressed according to NAS-
CET (North American Symptomatic Carotid Endar-
terectomy Trial) criteria (18). In a single study (19)
reporting stenosis according to ECST (European Ca-
rotid Surgery Trial) criteria, values were transformed
to NASCET values by using a published formula (20).
Degree of stenosis was categorized into mild (<50%),
moderate (50% to 69%), or severe (70% to 99%)
concordant with NASCET (3). Patients with asymp-
tomatic carotid stenosis were only included in the
current analysis if the degree of stenosis was $50%.
The primary outcome event in the current study
was ipsilateral hemispheric ischemic stroke (i.e.,
TABLE 1 Baseline Characteristics
Symptomatic
Carotid Stenosis
(n ¼ 560)
Asymptomatic
Carotid Stenosis
(n ¼ 136)
Total
(N ¼ 696)
Age at baseline, yrs 72.8  9.7 73.4  8.9 73.0  9.5
Male 387 (69.1) 115 (84.6) 502 (72.1)
Diabetes 125 (22.3) 31 (22.8) 156 (22.4)
Hypertension 370 (66.1) 105 (77.2) 475 (68.2)
Any smoking (former or current) 270 (48.2) 90 (66.2) 360 (51.7)
Statin treatment 370 (66.1) 109 (80.1) 479 (68.8)
Type of qualifying event
Stroke 285 (50.9) — 285 (40.9)
TIA 201 (35.9) — 201 (28.9)
AFx 74 (13.2) — 74 (10.6)
Asymptomatic — 136 (100) 136 (19.5)
Presence of IPH on baseline carotid MRI 289 (51.6) 40 (29.4) 329 (47.3)
Degree of stenosis
<50% 187 (33.4) — 187 (26.9)
50%–69% 192 (34.3) 128 (94.1%) 320 (46.0)
70%–99% 181 (32.3) 8 (5.9) 189 (27.2)
Time between qualifying event and MRI,
days
34.7  38.4 — —
Values are mean  SD or n (%). Some percentages do not add up to 100 because of rounding.
AFx ¼ amaurosis fugax; IPH ¼ intraplaque hemorrhage; MRI ¼ magnetic resonance imaging; TIA ¼ transient
ischemic attack.
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4occurring in the territory of the index carotid artery)
at any time after the MRI scan. Ischemic stroke was
clinically deﬁned as a rapidly developing syndrome of
focal cerebral dysfunction lasting >24 h or leading to
earlier death, with no other apparent cause than ce-
rebral ischemia. The secondary outcome event was
the composite of ipsilateral ischemic stroke, TIA, and
retinal ischemia.
In 1 study, IPH status and ipsilateral symptoms
during follow-up were reported for each side sepa-
rately in a minority of patients with bilateral carotid
stenosis (21). In these patients, if outcome events
occurred in both carotid territories or if no outcome
events occurred at all, we arbitrarily chose the right
carotid artery as the index artery; if outcome events
occurred only in 1 carotid territory, the ipsilateral
artery was chosen as the index artery. Patients with
simultaneous bilateral strokes were excluded to rule
out bias due to high likelihood of cardioembolic origin
(n ¼ 2) (22).
STATISTICAL ANALYSIS. Statistical analyses were
performed by an independent statistician (R.S.) using
SAS version 9.4 for Windows (SAS Institute, Inc.,
Cary, North Carolina). We compared outcome events
occurring during follow-up between patients with
IPH and those without IPH at baseline in the entire
study population and separately in patients with any
degree of symptomatic stenosis; patients with
symptomatic stenosis <50%, 50% to 69%, and 70% to99%; and patients with 50% to 99% asymptomatic
stenosis. Annualized event rates were calculated
from the sum of events and duration of follow-up. A
Kaplan-Meier analysis was performed comparing
time-to-event between patients with and without IPH
by using the log-rank test, and obtaining cumulative
risks after 3 months and 1, 2, 3, and 4 years, starting at
the time of the baseline plaque MRI scan and termi-
nating at the earliest occurrence of an outcome event.
If no outcome event occurred, analyses were
censored at the time of last available follow-up,
revascularization by carotid endarterectomy or
stenting, or death, whichever came ﬁrst.
Cox regression models were used to calculate un-
adjusted hazard ratios (HRs) of outcome events.
Frailty models were calculated modeling the time-to-
event adjusted for available clinical patient charac-
teristics, which had previously been identiﬁed as
independent predictors of ipsilateral stroke in pa-
tients with symptomatic carotid stenosis in the ECST:
age group, sex, diabetes, hypertension, degree of
stenosis, and symptoms at inclusion (23,24). Near
occlusion, time since last event, previous myocardial
infarction, peripheral vascular disease, and irregular/
ulcerated plaque (which are also part of the ECST risk
model) were not included because these variables
were not consistently available from the included
studies. To account for random effects of the indi-
vidual studies, frailty models were preferred to a
regular Cox regression.
All analyses were repeated for the secondary
composite outcome. A p value <0.05 was considered
to indicate statistical signiﬁcance.
RESULTS
Thirteen studies including 1,259 patients met the in-
clusion criteria (Figure 1). Individual patient data
were provided by researchers from 7 cohort studies
(n ¼ 696; Europe, n ¼ 4; Asia, n ¼ 2; North America,
n ¼ 1). Two of these studies included only patients
with asymptomatic carotid stenosis (19,21), 4 studies
included only patients with symptomatic stenosis
(16,25–27), and 1 study included both symptomatic
and asymptomatic patients (of which only the
symptomatic subset had been published) (22). In all
but 2 cohorts (21,25), follow-up for neurological
symptoms was prospective. Stroke was assessed as
clinical endpoint in all studies according to clinical
diagnosis and conﬁrmed by using neuroimaging in all
but 1 study (chart review only; 75 asymptomatic male
subjects) (21). Stroke and TIA were evaluated in all
studies and AFx in all but 2 studies (21,25). One study
used a 3.0-T MR scanner (22), and all other studies
TABLE 2 Annualized Rates for Ipsilateral Stroke During FU in Patients With and Without IPH at Baseline
IPH in the Baseline MRI Scan
TotalNo Yes
Events n
Mean Follow-Up
Duration,
months
AER,
% Events n
Mean Follow-Up
Duration,
months
AER,
% Events n
Mean Follow-Up
Duration,
months
AER,
%
Symptom status at baseline
Asymptomatic 2 96 33.3 0.8 4 40 22.4 5.4 6 136 30.1 1.8
Symptomatic 7 271 19.8 1.6 53 289 13.8 15.9 60 560 16.7 7.7
Stenosis category (symptomatic
patients)
<50% 1 103 15.8 0.7 13 84 20.5 9.0 14 187 18.0 5.0
50%–69% 5 97 30.1 2.1 25 95 17.4 18.1 30 192 23.8 7.9
70%–99% 1 71 11.6 1.5 15 110 5.6 29.3 16 181 8.0 13.3
Sex
Female 4 126 22.7 1.7 9 68 11.0 14.4 13 194 18.7 4.3
Male 5 241 23.6 1.1 48 261 15.9 13.9 53 502 19.6 6.5
Age, yrs
<65 2 87 19.5 1.4 7 40 12.8 16.5 9 127 17.3 4.9
65–74 2 114 23.0 0.9 17 110 16.8 11.0 19 224 19.9 5.1
>74 5 166 25.6 1.4 33 179 14.1 15.7 38 345 19.7 6.7
Total 9 367 23.3 1.3 57 329 14.9 14.0 66 696 19.3 5.9
AER ¼ annualized event rate; IPH ¼ intraplaque hemorrhage; MRI ¼ magnetic resonance imaging.
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5were performed on 1.5-T MR scanners. A multi-
sequence protocol (for detecting features additional
to IPH) and dedicated surface coils for imaging of the
vessel wall were used in 2 studies (19,26). MRI readers
were blinded to the clinical status in all studies.
During follow-up, subjects of all studies received best
medical treatment with antithrombotic therapy and
statins as applicable.
In the pooled study population (n ¼ 696), the mean
age at study inclusion was 73.0  9.5 years, 502 (72.1%)
patients were male, and 560 (80.5%) had symptomatic
carotid stenosis (Table 1). Among patients with
symptomatic carotid stenosis, the mean interval be-
tween the event and plaque MRI was 34.7 days. IPH
was detected at baseline in 51.6% (n ¼ 289) of patients
with symptomatic stenosis and in 29.4% (n ¼ 40) of
patients with asymptomatic stenosis. Among patients
with symptomatic and asymptomatic carotid stenosis
combined, IPH was present in 26.9%, 46.0%, and
27.2% of patients with a degree of stenosis <50%, 50%
to 69%, and 70% to 99%, respectively.
There were 1,121 person-years of follow-up in the
entire cohort, with a mean duration of 19.3 months
(16.7 months in patients with symptomatic stenosis
and 30.1 months in patients with asymptomatic
stenosis). Thirty-four patients died during
follow-up without occurrence of the primary or sec-
ondary outcome event, and 7 patients were censored
at the point where they underwent carotid
revascularization.During follow-up, 66 ipsilateral strokes occurred,
60 in patients with symptomatic stenosis (annualized
event rate [AER]: 7.7%) and 6 in patients with
asymptomatic stenosis (AER: 1.8%) (Table 2). Pres-
ence of IPH at baseline was associated with a signiﬁ-
cantly higher risk of ipsilateral stroke during
follow-up, both among patients with symptomatic
stenosis (AER: 15.9% vs. 1.6%; unadjusted HR: 10.2;
95% conﬁdence interval [CI]: 4.6 to 22.5) and among
patients with asymptomatic stenosis (AER: 5.4% vs.
0.8%; unadjusted HR: 7.9; 95% CI: 1.3 to 47.6)
(Figures 2 and 3). Cumulative risks are provided in
Figure 3. In patients with symptomatic carotid steno-
sis, the absolute difference in risk for ipsilateral stroke
between patients with and without IPH was 14.0%,
26.6%, and 33.5% at 1, 2, and 4 years, respectively.
The presence of IPH increased stroke risk in pa-
tients with symptomatic stenosis at all degrees: AER
of ipsilateral stroke in those with IPH versus without
IPH were 9.0% versus 0.7% in patients with <50%
stenosis, 18.1% versus 2.1% in patients with 50% to
69% stenosis, and 29.3% versus 1.5% in patients with
70% to 99% stenosis (Table 2). Unadjusted HRs for
ipsilateral stroke in patients with IPH versus those
without IPH in those categories of stenosis were 12.5
(95% CI: 1.6 to 96.5), 8.5 (95% CI: 3.2 to 22.4), and
15.9 (95% CI: 2.1 to 121.2), respectively (Figure 2,
Central Illustration).
The IPH-related increase in risk of ipsilateral stroke
among patients with symptomatic carotid disease
FIGURE 2 Associations Between Presence of IPH at Baseline and Ipsilateral Stroke During Follow-up
0.1
Events/Patients
11.2 (5.5 ; 22.7)
7.9 (1.3 ; 47.6)
15.9 (2.1 ; 121.2)
8.5 (3.2 ; 22.4)
12.5 (1.6 ; 96.5)
10.2 (4.6 ; 22.5)
Unadjusted
HR (95% CI)*
100%
20%
26%
28%
27%
80%
Weight
Overall
Asymptomatic, ≥50%
70-99%
Symptomatic, total
50-69%
<50%
IPH+
57/329
4/40
53/289
15/110
25/95
13/84
IPH–
9/367
2/96
7/271
1/71
5/97
1/103
200101
Plots show pooled estimates of associations between presence of intraplaque hemorrhage (IPH) at baseline and outcome during observed
follow-up. The area of each shaded box is proportional to the weight of the cohort it represents. *Estimated from a trial-stratiﬁed Cox
regression model. CI ¼ conﬁdence interval; HR ¼ hazard ratio; IPHþ/– ¼ IPH at baseline present/absent.
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6remained similar after multivariate adjustment for
known clinical risk predictors with an HR of 11.0
(95% CI: 4.8 to 25.1) (Table 3). In the multivariate
model, only severe degree of stenosis predicted ipsi-
lateral stroke in addition to IPH (HR: 3.3 [95% CI: 1.4
to 7.8] for 70% to 99% vs. <50% stenosis). No addi-
tional clinical risk predictors were identiﬁed after
removing IPH from the model (Supplemental
Table 6). After inclusion of patients with asymptom-
atic carotid stenosis and symptom status as an addi-
tional covariate in the model, IPH remained
signiﬁcantly associated with ipsilateral stroke risk
(HR: 10.4; 95% CI: 4.9 to 21.9); in addition, severe
degree of stenosis (HR: 3.0; 95% CI: 1.3 to 7.2) and
diabetes (HR: 2.0; 95% CI: 1.2 to 3.5) were positively
associated and asymptomatic status at baseline (HR:
0.3; 95% CI: 0.1 to 1.0) negatively associated with the
risk of ipsilateral stroke (Supplemental Table 7).
The secondary outcome event, the composite of
ipsilateral ischemic stroke, TIA, or AFx, occurred in
117 patients with symptomatic carotid stenosis and in
10 patients with asymptomatic carotid stenosis
(Supplemental Table 8). Presence of IPH resulted in a
signiﬁcantly increased risk of the secondary outcome
event, with unadjusted HRs of 6.5 and 14.5 for pa-
tients with symptomatic and asymptomatic stenosis,
respectively (Supplemental Figure 1). IPH remained a
signiﬁcant predictor of the secondary outcome event
after multivariate adjustment (Supplemental Tables 9
and 10).DISCUSSION
This study yielded several key ﬁndings. First, IPH
detectable by plaque MRI is common; in our study
population, it was present in 52% of patients with
previously symptomatic stenosis and in 29% of pa-
tients with asymptomatic carotid stenosis. Second,
IPH signiﬁcantly increased the risk of future ipsilat-
eral stroke in patients with symptomatic and
asymptomatic carotid stenosis, with unadjusted HRs
of 10.2 and 7.9, respectively. Third, in patients with
symptomatic carotid stenosis, IPH was associated
with an increased risk of stroke at any degree of ste-
nosis, even among patients with plaques
causing <50% narrowing. Fourth, among previously
symptomatic patients, only IPH and severe degree of
stenosis (70% to 99%) independently predicted ipsi-
lateral stroke in multivariate analysis, whereas other
known risk factors did not.
Carotid disease is an important cause of stroke.
Current guidelines, which are based on the results of
large trials conducted in the 1980s and 1990s,
recommend carotid endarterectomy in patients with
recently symptomatic severe (70% to 99%) carotid
stenosis and to consider carotid endarterectomy in
patients with symptomatic moderate (50% to 69%)
stenosis (28). Advances in medical therapy since
then, most notably the widespread use of statins,
more intensive antiplatelet regimens, lower targets
for blood pressure control, and increased awareness
FIGURE 3 Ipsilateral Stroke During Follow-up in Patients With Symptomatic and Asymptomatic Carotid Stenosis With and Without IPH at Baseline
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Kaplan-Meier plots show the proportion of patients free of ipsilateral ischemic stroke. (A) All patients with symptomatic carotid stenosis. (B) Patients
with $50% asymptomatic carotid stenosis. Numbers adjacent to plots indicate cumulative risks of ipsilateral stroke. Beyond 48 months, 4 more strokes
occurred in patients with symptomatic carotid stenosis (3 of which occurred in IPHþ patients). Abbreviations as in Figure 2.
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7of vascular risk factors, have led to a decrease in
stroke risk in patients with carotid disease. Accord-
ingly, the risk of stroke after a TIA due to large artery
atherosclerosis has dropped from as high as 20% after
3 months (29,30) to only 6% (31). Consequently, the
numbers of patients needed to revascularize to pre-
vent one stroke are likely higher today than they used
to be. Thus, identifying patients at risk has become
paramount to avoid unnecessary procedures.
Previous studies have reported a 4- to 12-fold in-
crease in the risk of cerebrovascular events in the
presence of IPH (14–16). However, these studies often
reported on combined risks of stroke and TIA, pre-
cluding meaningful estimations of stroke risk. Sec-
ond, single studies were too small to investigate if
IPH adds prognostic value to established models
based on readily available clinical and imaging char-
acteristics (23) such as the degree of stenosis.
By pooling data at individual patient level from
several prospective studies, we were able to over-
come these limitations. Our study showed that if IPH
was present at baseline, patients with mild (<50%),
moderate (50% to 69%), or severe (70% to 99%)
symptomatic carotid stenosis were at high risk of
ipsilateral stroke during follow-up, with estimatedannualized rates of 9.0%, 18.1%, and 29.3%, respec-
tively. Conversely, the event rates were low if IPH
was absent, irrespective of the degree of stenosis
(0.7%, 2.1%, and 1.5%), and notably did not differ
materially from the event rate observed among pa-
tients with asymptomatic carotid stenosis without
IPH (0.8%). Hence, among patients with symptomatic
carotid stenosis, IPH is a much stronger predictor of
stroke risk than the degree of stenosis or symptom
status and potentially a more useful marker to select
patients who beneﬁt from revascularization or, vice
versa, to identify those who can safely be treated with
medication alone.
Our ﬁnding of an increased future stroke risk
among patients with hemorrhaged plaques
causing <50% stenosis ipsilateral to the qualifying
event is of particular interest. Plaque MRI would
potentially allow attributing large artery atheroscle-
rosis as the presumed cause of stroke, TIA, or AFx in
patients with ipsilateral plaques causing <50% ste-
nosis if IPH is present, provided that other etiologies
have been ruled out. Current guidelines do not
recommend endarterectomy or stenting in patients
with carotid plaques causing <50% narrowing of the
lumen, although our results suggest that some of
CENTRAL ILLUSTRATION Ipsilateral Stroke During Follow-up in Patients With Mild, Moderate, and Severe
Symptomatic Carotid Stenosis With and Without IPH at Baseline
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Kaplan-Meier plots show the proportion of patients free of ipsilateral ischemic stroke. (A) Less than 50% stenosis, (B) 50% to 69% stenosis, and (C) 70% to 99%
stenosis. Numbers adjacent to plots indicate cumulative risks of ipsilateral stroke. Abbreviations as in Figure 2.
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TABLE 3 Multivariate Model of Time to Ipsilateral Stroke According to Baseline
Characteristics in All Patients With Symptomatic Carotid Stenosis
Studies n
Adjusted Hazard Ratio
(95% CI) p Value
Age, yrs
<65* 5 105 1.00
65–74 5 179 0.7 (0.3–1.7) 0.44
>74 5 274 0.8 (0.4–1.9) 0.68
Sex
Male* 5 385
Female 4 173 1.0 (0.5–2.1) 0.95
Diabetes mellitus
No* 5 433
Yes 5 125 1.8 (1.0–3.2) 0.06
Hypertension
No* 5 189
Yes 5 369 1.1 (0.5–2.2) 0.80
Degree of stenosis
<50%* 4 186 1.00
50%–69% 5 191 2.0 (1.0–4.3) 0.06
70%–99% 3 181 3.3 (1.4–7.8) 0.005
Type of qualifying event
Stroke* 5 284 1.00
TIA 5 200 1.1 (0.6 –2.0) 0.75
Retinal ischemia (including retinal
infarction and AFx)
5 74 0.4 (0.1–1.2) 0.11
IPH at inclusion
No* 4 271
Yes 5 287 11.0 (4.8–25.1) <0.0001
Data derived from frailty model. Individual data of 2 patients were incomplete. *Reference category.
CI ¼ conﬁdence interval; other abbreviations as in Table 1.
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9these patients might beneﬁt from carotid revascular-
ization, which remains to be proven in clinical trials.
Plaque-imaging studies or other ancillary in-
vestigations to estimate the risk of stroke in patients
with carotid disease are only useful in clinical practice
if they add prognostic value to validated (and readily
available) clinical risk factors. A model to predict the
risk of stroke in patients with symptomatic carotid
stenosis under medical therapy derived in the ECST
study population includes degree of stenosis in addi-
tion to various other clinical and demographic patient
characteristics (24). When we included IPH and those
variables of the aforementioned risk model that were
available from the contributing studies in a multivar-
iate model, we found that only IPH and severe degree
of stenosis remained signiﬁcantly associated with the
occurrence of ipsilateral stroke, the association being
much stronger for IPH than for severe stenosis
(adjusted HRs of 11.0 and 3.3, respectively). These
ﬁndings are in line with those of previous studies, in
which IPH predicted recurrent cerebrovascular
events, whereas the ECST risk model failed to do so
(22,32). Thus, a model including both IPH and clinical
variables would likely be superior in identifying pa-
tients at risk compared with a model based on clinical
data alone. However, this hypothesis requires proof in
a separate cohort.
Identifying those patients at risk of stroke who
might beneﬁt from revascularization is even more
crucial among patients with asymptomatic carotid
disease, who have a much lower risk of stroke. Trends
of decreasing stroke risks over the years have been
suggested in these patients by means of meta-
regression (33), and it is no longer clear that the
moderate beneﬁt of revascularization in preventing
stroke seen in earlier trials is still present in the
context of modern medical therapy. At the same time,
detection of individuals without IPH and thus lower
risk for future events could prevent unnecessary
revascularization and its inherent risks and costs. The
potential beneﬁts of improved patient identiﬁcation
for revascularization by using MRI are supported by
case model–based cost-effectiveness analyses. These
analyses show that an imaging-based strategy for
selection of patients with asymptomatic carotid ar-
tery stenosis for surgery can be a cost-effective
approach compared with intensiﬁed medical treat-
ment alone, with the highest value in relatively
younger patients (34). Our study found an increase in
stroke risk among asymptomatic patients with IPH at
baseline compared with those without (AER: 0.8% vs.
5.4%; unadjusted HR: 7.9). The small sample size
limits comparability of our ﬁndings with the risk in-
crease conveyed by the presence of micro-embolicsignals in transcranial Doppler (HR: 6.4) (35) or
juxta-luminal areas of low echogenicity in gray scale
ultrasound (HR: 2.3) (36), as reported in much larger
studies of asymptomatic patients. It remains to be
shown in larger cohorts if a combination of these
complementary imaging studies identiﬁes patients at
sufﬁciently high risk of stroke to justify carotid
revascularization.
In addition to comprehensive risk factor manage-
ment, current guidelines recommend a sufﬁcient an-
tiplatelet and lipid-lowering therapy for symptomatic
and asymptomatic individuals (28). Interestingly, in
our population, statin treatment at baseline was more
widespread in asymptomatic individuals. A possible
explanation might be that asymptomatic individuals
had a higher prevalence of pre-existing cardiovascu-
lar disease (e.g., congenital heart disease) and thus
already were on intensive medication at baseline.
This explanation remains speculative, however,
because data for concomitant vascular disease were
not available in all patients.
STUDY LIMITATIONS. Only 7 of the 13 identiﬁed
eligible cohort studies provided individual patient
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE 1: IPH
detected by using carotid MRI is a marker of plaque
instability that is strongly associated with the future
risk of stroke irrespective of symptom status or
stenosis degree and is a stronger predictor of stroke
risk than previously known clinical risk factors.
COMPETENCY IN MEDICAL KNOWLEDGE 2: IPH
may already be present in symptomatic vessels
with <50% stenosis and increase the risk for stroke.
Evaluation of carotid disease should thus extend
beyond establishing the degree of stenosis.
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS 1: Additional MRI of the
carotid arteries in stroke patients may reveal instable
atherosclerotic plaque and enable for a more individ-
ualized primary and secondary prevention of stroke.
COMPETENCY IN PATIENT CARE AND
PROCEDURAL SKILLS 2: Diagnosis of carotid IPH
can readily be diagnosed by using a standard MRI neck
coil in a 5-min MRI protocol that can be implemented
in clinical MRI stroke protocols.
TRANSLATIONAL OUTLOOK 1: Risk models
including IPH along with clinical variables are likely to
improve the identiﬁcation of patients who beneﬁt
most from carotid revascularization.
TRANSLATIONAL OUTLOOK 2: Further studies
are needed to determine the optimal selection of
patients for revascularization and to investigate the
beneﬁt of revascularization versus medical therapy
alone based on carotid plaque MRI or other extended
imaging.
Schindler et al. J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . - , N O . - , 2 0 1 9
Carotid Plaque Hemorrhage Predicts Stroke - 2 0 1 9 :- –-
10data for a pooled analysis. Most of the included studies
were not initially designed to follow up their patients
for 4 years, explaining the relatively rapid decrease in
the number of patients at risk. Studies differed in in-
clusion criteria and mode of follow-up. Furthermore,
in most of the studies including patients with symp-
tomatic carotid stenosis, the interval between the
qualifying event and carotid MRI was relatively long;
hence, we cannot draw any conclusions about the very
early risk of recurrent stroke after the initial event.
Relatively few patients with asymptomatic carotid
stenosis were included, and most of them had only a
moderate degree of narrowing. Hence, we cannot
draw ﬁrm conclusions on the usefulness of plaqueMRI
in patients with asymptomatic stenosis. Finally, only
the originally collected individual patient data were
available for evaluation. Thus promising, yet techni-
cally and timely more demanding, parameters such as
plaque volume (37) or lipid content (12) could not be
evaluated.
For detection of IPH, T1-weighted sequences
remain the method of choice. In recent years, three-
dimensional isotropic MR imaging sequences, which
have also been applied in the majority of included
studies, have been proposed for plaque imaging.
Compared with two-dimensional sequences, these
sequences allow for a more detailed plaque charac-
terization and accurate quantiﬁcation of plaque
components at a high spatial resolution and scan
times <5 min (38). Magnetization-prepared rapid
gradient-echo sequences have been found to be even
superior to fast-spin echo T1-weighted images (39).
Further optimizations have led to simultaneous
noncontrast angiography and intraplaque hemor-
rhage imaging sequences (40); once made commer-
cially available, these imaging sequences might be
implemented as an angiographic technique in clinical
routine carotid MRI examinations with simultaneous
detection of IPH at no additional cost.
CONCLUSIONS
Detection of IPH by using MRI is common and asso-
ciated with an increased risk of future stroke in pa-
tients with symptomatic carotid stenosis irrespective
of the degree of luminal narrowing, as well as in pa-
tients with $50% asymptomatic carotid stenosis.
Among recently symptomatic patients, the associa-
tion of IPH with future stroke risk is much stronger
than that of previously known clinical risk factors and
independent of these factors. Thus far, data on
the additional beneﬁt of IPH-guided surgical, inter-
ventional, or therapeutic approaches are limited, andthe risk and optimal timing of carotid revasculariza-
tion in high-risk plaques are unknown. Our results
support the need for clinical trials selecting patients
for revascularization or investigating the beneﬁt of
revascularization versus medical therapy alone based
on carotid plaque MRI or other extended imaging.
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